[1] 大山哲司，吉村公雄，柳川堯
共通オッズ比を用いるHardy-Weinberg平衡の検証
計量生物学, 27, 2, 97-108, 2006.
[2] Takeshi Hano, Yuji Oshima, Masato Kinoshita, Minoru Tanaka, Noriko Mishima, Tetsuji Ohyama, Takashi Yanagawa, Yuko Wakamatsu, Kenjiro Ozato, and Tsuneo Honjo
Quantitative Bioimaging Analysis of Gonads in olvas-GFP/ST-II YI Medaka (Transgenic Oryzias latipes) Exposed to Ethinylestradiol
Environmental Science & Technology, 41, 1473-1479, 2007.
[3] Tetsuji Ohyama, Jimmy A. Doi, Takashi Yanagawa
Estimating population characteristics by incorporating prior values in stratified random sampling/ranked set sampling
Journal of Statistical Planning and Inference, 138, 4021-4032, 2008.
[4] Takashi Yanagawa, Satoshi Aoki and Tetsuji Ohyama
DIVERSITY OF HUMAN FINGER VEIN PATTERNS AND ITS APPLICATION TO PERSONAL IDENTIFICATION
Bulletin of Informatics and Cybernetics, 41, 1-9, 2009.
[5] Natsumi Yamashita, Eiko Nagata, Tetsuji Ohyama, Takashi Yanagawa
MODELING TRANSITION PROBABILITIES AND DURATION TIME FOR EVENT HISTORY DATA
Bulletin of Informatics and Cybernetics, 42, 71-79, 2010.
[6] Junko Imanaga, Tsutomu Kotegawa, Hiromitsu Imai, Kimiko Tsutsumi, Tsuneaki Yoshizato, Tetsuji Ohyama, Yoshiyuki Shirasaka, Ikumi Tamai, Tomonori Tateishi and Kyoichi Ohashi
The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans
Pharmacogenetics and Genomics, 21, 84-93, 2011.
[7] Tsuneaki Yoshizato, Tsutomu Kotegawa, Hiromitsu Imai, Kimiko Tsutsumi, Junko Imanaga, Tetsuji Ohyama, Kyoichi Ohashi
Itraconazole and domperidone: a placebo-controlled drug interaction study
Eurpean Journal of Clinical Pharmacology, 68, 1287-1294, 2012.
[8] Tsutomu Kotegawa, Kimiko Tsutsumi, Hajime Morita, Hiromitsu Imai, Misaki Morita, Tsuneaki Yoshizato, Tetsuji Ohyama, Shinya Uchida, Hiroshi Watanabe, Noriyuki Namiki, Kyoichi Ohashi
Effects of dosing interval on the pharmacokinetic and pharmacodynamic interactions between the oral adsorbent AST-120 and triazolam in humans
Eurpean Journal of Clinical Pharmacology, 68, 1605-1610, 2012.
[9] Tetsuji Ohyama
Prior value incorporated calibration estimator in stratified random sampling
Statistics and Probability Letters, 83, 46-51, 2013.
[10] Yuki Suzaki, Naoto Uemura, Makoto Takada, Tetsuji Ohyama, Akiko Itohda, Takuya Morimoto, Hiromitsu Imai, Hajime Hamasaki, Akihiro Inano, Masakiyo Hosokawa, Masato Tateishi, Kyoichi Ohashi
The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans
European Journal of Clinical Pharmacology, 69, 21-30, 2013
[11] Takanori Iriuchisima, Keinosuke Ryu, Shin Aizawa, Hiroshi Yorifuji, Tetsuji Ohyama, Freddie H. Fu
Anterior cruciate ligament deterioration correlates with patella osteoarthritis
International Orthopaedics, 2013
[1] 大山哲司，吉村公雄，柳川堯
共通オッズ比を用いるHardy-Weinberg平衡の検証
日本計量生物学会，2005
[2] 柳川堯，青木敏，大山哲司
指静脈の多様性と生体認証への応用
応用統計学会，2007
[3] Tetsuji Ohyama, Jimmy A. Doi , Takashi Yanagawa
Empirical Bayes estimator in stratified random sampling / ranked set sampling
Joint Statistical Meeting 2007
[4] 大山哲司，Jimmy A. Doi，柳川堯
Empirical Bayes estimator in stratified random sampling / ranked set sampling
統計関連学会連合大会，2007
[5] 大山哲司，Jimmy A. Doi，柳川堯
Estimating Population Characteristics by Incorporating Prior Values in Stratified Random Sampling/Ranked Set Sampling
バイオ統計フォーラム，2007
[6] 山下夏美，永田榮子，大山哲司，柳川堯
異なったイベントの繰り返しを持つ追跡データのマルコフモデリング
統計関連学会連合大会，2008
[7] Tetsuji Ohyama, Natsumi Yamashita, Eiko Nagata, Takashi Yanagawa
Modeling Transition Probabilities and Duration Time for Event History Data
Kurume International Symposium on Biostatistics, 2009
[8] 大山哲司，Jimmy A. Doi，柳川堯
Estimating Population Characteristics by Incorporating Prior Values in Stratified Random Sampling/Ranked Set Sampling
大分統計談話会，2009
[9] 江島伸沖，大山哲司
一般化線形モデルのパス分析
統計関連学会連合大会，2010
[10] Eshima, N., Ohyama, T., Tabata, M., Asano, C.
Path analysis of generalized linear models based on the entropy coefficient
The 10th China-Japan symposium on Statistics, 2010
[11] 大山哲司，小手川勤，堤喜美子，倉成正恵，今井浩光，大橋京一，中野重行
Quazepamの薬理効果に及ぼす代謝物N-desalkyl-2-oxoquazepamの関与について
第32回日本臨床薬理学会年会，2011
[12] 須崎友紀，森本卓哉，伊藤田瑛子，高田誠，今井浩光，大山哲司，濱崎一，上村尚人，廣田和仁，
稲野彰洋，立石正登，大橋京一
オセルタミビル（タミフル®）の薬物動態に及ぼすCES1A遺伝子多型の影響
第32回日本臨床薬理学会年会，2011
[13] 今井浩光，森田美咲，森田元，大山哲司，伊藤田瑛子，須崎友紀，森本卓哉，小手川勤，田中紫茉子，
内田信也，並木徳之，大橋京一
ブプレノルフィンの薬理作用におけるオピオイドμ1受容体遺伝子多型（118A>G）の影響
第32回日本臨床薬理学会年会，2011
[14] 大山哲司
層別無作為抽出法において事前情報と補助変数を組み込んだ母集団特性値の推定
統計関連学会連合大会，2012
[15] 浜崎一，今井浩光，石井宏治，前島圭佑，鈴木陽介，大山哲司，小手川勤，大橋京一
全身性エリテマトーデスの維持療法におけるタクロリムス血中濃度とCYP3A5遺伝子多型との関連
第33回日本臨床薬理学会学術総会，2012
[16] 大山哲司，江島伸興
処置前後での連続なbounded outcome scoresの変化に対する2変量ベータ分布を用いた解析
日本計算機統計学会第27回シンポジウム，2013
[17] Tsutom Kotegawa, In-Jin Jang, Ichiro Ieiri, Shinya Uchida, Hiromitsu Imai, Seokuee Kim, Masato Fukae, Tetsuji Ohyama, Hajime Hamasaki, Kimiko Tsutsumi, Eiji Uchida, Kyoichi Ohashi
Effects of the OATP2B1 C1457 Polymorphism and apple juice on the pharmacokinetics and pharmacodynamics of acebutolol in humans
第34回日本臨床薬理学会学術総会，2013